House Passes 2026 Farm Bill as November Hemp THC Ban Stays on Track
The bill redefines hemp using total THC but does nothing to delay the looming November 12 product ban that threatens a $28 billion market.
By CBDWorldNews Editorial Staff | May 15, 2026
The U.S. House voted 224-200 on April 30 to pass the Farm, Food, and National Security Act of 2026, sending the bill to the Senate with its hemp provisions largely unchanged. Most notably absent from the final text: any language to delay or soften the federal ban on intoxicating hemp products set to take effect November 12.
A New Definition of Hemp
The bill rewrites the federal definition of hemp, shifting from the delta-9 THC threshold established in the 2018 Farm Bill to a total THC standard that includes THCA. Under the new framework, hemp must test below 0.3% total THC, accounting for decarboxylation. Finished consumer products face an even tighter standard: a cap of 0.4 milligrams of total THC per container.
That change closes what lawmakers on both sides have called the “hemp loophole,” a gap that allowed products containing delta-8 THC, delta-10 THC, and other psychoactive cannabinoids to flood retail shelves in states where cannabis remains illegal.
Bipartisan Amendments Pulled at the Last Minute
Several bipartisan lawmakers filed amendments that would have regulated hemp THC products and pushed back the ban’s effective date. Those proposals were withdrawn before the vote for reasons that remain unclear, frustrating industry advocates who had lobbied for a two-year transition period.
The U.S. Hemp Roundtable and other trade groups have warned that the November deadline could wipe out $13.2 billion in wages and devastate rural economies that pivoted to hemp cultivation after the 2018 Farm Bill opened the market.
What the Senate May Do Differently
The bill now heads to the Senate, where hemp-related provisions are likely to receive more attention. Sen. Rand Paul (R-Ky.) filed the Hemp Safety Enforcement Act on April 16, which would allow states to opt out of the intoxicating product ban. Sen. Mitch McConnell (R-Ky.), who helped craft the original 2018 hemp legalization language, has backed the restrictions heading into November.
“We are asking Congress for time to build a regulatory framework that protects consumers and preserves jobs. Six months is not enough.” — U.S. Hemp Roundtable
Industry watchers expect the Senate to mark up its own version of the Farm Bill this summer, creating a narrow window for hemp-related negotiations before the November 12 deadline arrives.
Relief for Industrial Hemp Growers
One bright spot in the House-passed bill: provisions aimed at reducing regulatory burdens for industrial hemp producers. The bill would authorize the USDA to reduce or eliminate certain testing requirements and background checks for farmers growing non-consumable hemp for fiber, grain, and industrial applications.
That distinction matters. While the consumable hemp-derived THC market faces an existential threat, the industrial hemp sector has pushed for years to separate itself from the controversy surrounding intoxicating products.
What Comes Next
The clock is running. The Continuing Appropriations and Extensions Act of 2026 set November 12 as the date when most psychoactive hemp-derived cannabinoids become federally illegal. Without legislative intervention, products currently sold in gas stations, smoke shops, and online retailers across the country will be treated as controlled substances.
For businesses that built their operations around hemp-derived THC products, the next several months will determine whether Congress provides a pathway forward or lets the ban take effect as written.
If you are currently purchasing CBD products, understanding how to verify product quality through third-party lab testing becomes more important as the regulatory landscape shifts. For consumers exploring their options before any changes take effect, our 2026 CBD buying guide on CBDProducts.com breaks down what to look for in a quality product.
These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure, or prevent any disease.
